{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-021195","form_type":"8-K","ticker":"MAIA","cik":"0001878313","company_name":"MAIA Biotechnology, Inc.","filed_at":"2025-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.952558+00:00","generated_at":"2026-05-16T23:09:06.032555+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"MAIA Biotechnology presents THIO-104 and THIO-101 posters at SITC 2025 for NSCLC trials","bullets":["THIO-104 Phase 3 study of ategano sine (THIO) sequenced with ICI vs SOC chemo in ICI-resistant advanced NSCLC presented Nov 7.","THIO-101 Phase 2 study of THIO combined with ICI in advanced NSCLC resistant to prior ICI and chemo presented Nov 10.","Posters are in-progress trial updates and contain forward-looking statements; detailed results not disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-021195","json":"https://secwatch.observer/filing/0001493152-25-021195.json","markdown":"https://secwatch.observer/filing/0001493152-25-021195.md","text":"https://secwatch.observer/filing/0001493152-25-021195.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1878313/000149315225021195/0001493152-25-021195-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1878313/000149315225021195/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:09:06.032555+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}